Feb 10, 2026Nicotinamide Riboside and Nicotinamide: NAD+ Precursor Comparison and Human Trial EvidenceNicotinamide riboside (NR) and plain nicotinamide both raise NAD+ but through different pathways and with different safety profiles. NR has more published human trials; nicotinamide is cheaper but raises sirtuin-inhibition concerns at high doses.